These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3667711)
21. Identification of a biochemical difference between male and female human fibroblasts: implications for the expression of Duchenne muscular dystrophy. Davis MH; Pato CN; Grinvalsky H; Gruenstein E Neurology; 1982 Sep; 32(9):951-7. PubMed ID: 7202167 [TBL] [Abstract][Full Text] [Related]
22. The differential effects of calcium starvation on Duchenne muscular dystrophy fibroblasts. Mone J; Lefkowitz SS Proc Soc Exp Biol Med; 1988 Mar; 187(3):267-72. PubMed ID: 3347605 [TBL] [Abstract][Full Text] [Related]
23. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts. Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800 [TBL] [Abstract][Full Text] [Related]
24. Duchenne muscular dystrophy: lack of differences in the expression of endogenous carbohydrate- and heparin-binding proteins (lectins) in cultured fibroblasts. Stulnig T; Schweiger M; Hirsch-Kauffmann M Eur J Cell Biol; 1993 Oct; 62(1):173-81. PubMed ID: 8269975 [TBL] [Abstract][Full Text] [Related]
25. Analysis of skin fibroblast aggregation in Duchenne muscular dystrophy. Jones GE; Witkowski JA J Cell Sci; 1981 Apr; 48():291-300. PubMed ID: 7276091 [TBL] [Abstract][Full Text] [Related]
26. Ribosomal protein synthesis in cultured skin fibroblast cells obtained from patients with Duchenne muscular dystrophy. Pöche H; Schulze H J Neurol Sci; 1985 Oct; 70(3):295-304. PubMed ID: 4056825 [TBL] [Abstract][Full Text] [Related]
27. Free cytoplasmic Ca++ at rest and after cholinergic stimulus is increased in cultured muscle cells from Duchenne muscular dystrophy patients. Mongini T; Ghigo D; Doriguzzi C; Bussolino F; Pescarmona G; Pollo B; Schiffer D; Bosia A Neurology; 1988 Mar; 38(3):476-80. PubMed ID: 3347352 [TBL] [Abstract][Full Text] [Related]
28. Defective Ca2+ metabolism in Duchenne muscular dystrophy: effects on cellular and viral growth. Fingerman E; Campisi J; Pardee AB Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7617-21. PubMed ID: 6095311 [TBL] [Abstract][Full Text] [Related]
29. Fibroblast cultures in Duchenne muscular dystrophy. Alterations in synthesis and secretion of collagen and noncollagen proteins. Ionasescu V; Lara-Braud C; Zellweger H; Ionasescu R; Burmeister L Acta Neurol Scand; 1977 May; 55(5):407-17. PubMed ID: 857578 [TBL] [Abstract][Full Text] [Related]
30. Abnormal protein metabolism in skin fibroblasts in vitro from patients with Duchenne muscular dystrophy. Rodemann HP; Bayreuther K; Schumacher E Biochem Biophys Res Commun; 1987 May; 145(1):1-9. PubMed ID: 3593332 [TBL] [Abstract][Full Text] [Related]
31. Comparison between the growth pattern of cell cultures from normal and Duchenne dystrophy muscle. Delaporte C; Dehaupas M; Fardeau M J Neurol Sci; 1984 May; 64(2):149-60. PubMed ID: 6747662 [TBL] [Abstract][Full Text] [Related]
32. Biochemical investigations in cultured skin fibroblasts from patients with Duchenne muscular dystrophy. Pena SD; Vust A; Tucker D; Hamerton JL; Wrogemann K Clin Genet; 1978 Jul; 14(1):50-4. PubMed ID: 679522 [TBL] [Abstract][Full Text] [Related]
33. Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy. Miranda AF; Francke U; Bonilla E; Martucci G; Schmidt B; Salviati G; Rubin M Am J Med Genet; 1989 Feb; 32(2):268-73. PubMed ID: 2648829 [TBL] [Abstract][Full Text] [Related]
34. Skewed X inactivation in manifesting carriers of Duchenne muscular dystrophy. Yoshioka M; Yorifuji T; Mituyoshi I Clin Genet; 1998 Feb; 53(2):102-7. PubMed ID: 9611069 [TBL] [Abstract][Full Text] [Related]
35. Allosteric transition of erythrocyte alkaline phosphatase from Duchenne muscular dystrophy (DMD) patients and Duchenne muscular dystrophy carriers (Homo sapiens). Goldemberg AL; García AM; Fernández H; Fortunato M; Sánchez JJ; Trucco RE Int J Biochem; 1988; 20(7):703-6. PubMed ID: 2846381 [TBL] [Abstract][Full Text] [Related]
36. Duchenne muscular dystrophy: studies of cell motility in vitro. Witkowski JA; Dubowitz V J Cell Sci; 1985 Jun; 76():225-34. PubMed ID: 4066788 [TBL] [Abstract][Full Text] [Related]
37. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. Mizuno Y; Nonaka I; Hirai S; Ozawa E J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010 [TBL] [Abstract][Full Text] [Related]
38. Comparison of Duchenne and normal myoblasts from a heterozygote. Hurko O; McKee L; Zuurveld J; Swick HM Neurology; 1987 Apr; 37(4):675-81. PubMed ID: 3561779 [TBL] [Abstract][Full Text] [Related]
39. [Duchenne muscular dystrophy carrier presenting with mosaic X chromosome constitution and muscular symptoms--with analysis of the barr bodies in the muscle]. Kinoshita M; Ikeda K; Yoshimura M; Saku A; Watanabe K Rinsho Shinkeigaku; 1990 Jun; 30(6):643-6. PubMed ID: 2225660 [TBL] [Abstract][Full Text] [Related]
40. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy. Bonilla E; Schmidt B; Samitt CE; Miranda AF; Hays AP; de Oliveira AB; Chang HW; Servidei S; Ricci E; Younger DS Am J Pathol; 1988 Dec; 133(3):440-5. PubMed ID: 3059802 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]